Prof. Dr. Fahd Al-Mulla currently works in the Genetics and Bioinformatics Department at the Dasman Diabetes Institute, Dasman, Kuwait. He graduated in Medicine from Glasgow University in 1993. He is a Fellow of the Royal College of Physicians of Edinburgh. His research activities focus on cancer and diabetes. He has pioneered the use of next-generation sequencing and microarrays in diagnostics and precision medicine. He has extensive experience in genomic-related technologies and intellectual property development. He currently holds six patents related to diabetes, wound healing, and cancer. He serves as a chair of the Evidence group in the Global Genomic Medicine Collaborative and of the International Confederation of Countries Advisory Council of the Human Variome. He was awarded the prestigious Kuwait Foundation for the Advancement of Sciences Scientific Production Prize in 2015.